• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Roche launches its connected blood glucose meter in Europe

January 12, 2022 By Sean Whooley

Roche logo - updatedRoche announced today that it launched its Cobas Pulse system in select countries accepting CE mark approval in Europe.

Basel, Switzerland–based Roche designed its Cobas Pulse system to combine the form factor of a high-performance blood glucose meter with simple usability and expanded digital capabilities comparable to that of a smartphone. The platform joins Roche’s connected point-of-care solution portfolio.

According to a news release, it’s possible to use the Cobas Pulse system across a range of care settings needing timely and informed clinical decisions. In addition, Roche says it can simplify workflows for busy nurses and doctors and improve their ability to deliver bedside care.

Cobas Pulse includes digital health applications based on the Android operating system that perform clinically valuable functions. It has decision support and measurements of vital signs and digital biomarkers. Roche’s newest module in the Cobas Infinity Edge suite of software solutions, Smart, enables the selected apps within the platform.

The company has several partnerships, including Glytec, CardioSignal and SteadySense, and plans to seek CE IVDR and FDA clearance for the Cobas Pulse system in other markets throughout the coming year.

“Frontline health workers are under increasing pressure to not only accurately diagnose patients, but also make appropriate decisions on all aspects of disease management and patient care,” Roche Diagnostics CEO Thomas Schinecker said in the release. “Our commitment is to equip them with high-performance innovations that represent a real step-change in their working lives. We are pleased to introduce a truly novel solution that puts actionable clinical insights, and a near limitless range of digital capabilities for patient care, in the palms of their hands.”

Filed Under: Diabetes, Featured, Hospital Care, Patient Monitoring, Regulatory/Compliance Tagged With: Roche

IN CASE YOU MISSED IT

  • FDA approves Medtronic’s Onyx Frontier drug-eluting coronary stent
  • Medtronic completes Intersect ENT acquisition
  • Abbott announces availability of Xience Skypoint drug-eluting stent in extended sizes
  • Here’s what’s next for Insulet after the launch of Omnipod 5, CEO change
  • Senseonics beats The Street in Q1 following Eversense E3 launch

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS